Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

1,000+ kids tracked from birth to unlock secrets of childhood lung infections

NCT ID NCT07249996

Knowledge-focused Sponsor: Eduardo Lopez -Medina Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 1,088 newborns in Colombia and Panama until age 5 to learn how often respiratory infections happen, which viruses or bacteria cause them, and why some children get sicker than others. Families report symptoms twice a week and provide nasal and blood samples during illnesses. No experimental treatments are given—the goal is to gather information that could improve future prevention and care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help scientists better understand why some children get severe respiratory infections and how early infections affect long-term lung health, guiding future prevention and treatment strategies.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test any new therapy. Results may take years to emerge and might not apply to children outside Colombia and Panama.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,088 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2024

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Newborns younger than 29 days of life, with or without pre-existing conditions

Ages

Up to 29 days

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Newborns younger than 29 days of life, with or without pre-existing conditions * Infants whose parent(s) or guardian(s) are available for telephone contact for the duration of the study, and do not intend to relocate outside of the study area, to ensure adherence to RTI and in-person visits. * Infants whose parent(s) or guardian(s) provide informed consent to participate in the study. * Infants whose parent(s) or guardian(s) are willing to authorize data and specimen collection, storage and analysis. Exclusion Criteria: * Infants born to a pregnant mother under 14 years of age (under Colombian law, pregnancies occurring in individuals younger than 14 years of age are legally presumed to result from sexual abuse).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cohort study are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lower respiratory tract disorder respiratory tract infectious disorder viral infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cohort study Lower respiratory tract infection (LRTI) Respiratory tract infections (RTI) Viral infections

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centro de Estudios en Infectologia Pediatrica, CEIP

    RECRUITING

    Cali, Valle del Cauca Department, Colombia

  • Cevaxin

    RECRUITING

    Panama City, Panama

More trials for these conditions

Other studies related to the condition(s) this trial covers.